Associate Professor
a.p Abdulfattah Abbas
- مدرس سابق
Novel immunotherapeutic options for BCG-unresponsive high-risk non-muscle-invasive bladder cancer
online library wiley1 - December - 2023
High-risk non-muscle-invasive bladder cancer (HR-NMIBC) presents a challenge to many physicians due to its ability to resist Bacillus Calmette–Guérin (BCG) intravesical therapy and the substantial rate of progression into muscle-invasive bladder cancer (MIBC). Patients who are BCG-unresponsive have worse prognosis and thus require further management including radical cystectomy (RC), which significantly impacts quality of life
Download FileThe relationship between breakfast and academic achievement among students of medical colleges at Al Andalus university sciences
International Journal of Dental and Health Sciences22 - September - 2018
